玻璃酸钠治疗早、中期膝关节骨性关节炎的疗效分析  

Study of effect of Sodium Hyaluronate for the freatment of initial knee osteoarthritis

作　　者：王伟[1] 冯亮[1] 刘淑华[1] 

机构地区：[1]吉林油田总医院外科门诊,138000

出　　处：《中国现代药物应用》2012年第17期18-19,共2页Chinese Journal of Modern Drug Application

摘　　要：目的探讨玻璃酸钠(SH)关节腔内注射对膝关节骨性关节炎的疗效。方法将84例患者随机分为玻璃酸钠注射组(SH)和物理治疗组(对照组),对两组患者治疗前后进行膝关节功能综合评分,并对68例随访患者分别于治疗后3个月、6个月、1年时评定疗效。结果治疗时间太短膝关节功能综合评分两组无统计学差异;随访结果疗效优良率SH组明显优于对照组。结论关节腔内注射玻璃酸钠治疗早、中期膝关节骨关节炎远期疗效持久、稳定。Objective To study the effect of initial middle articular injection of sodium hyaluronate （SH） for the treatment of knee osteoarthritis （OA）. Methods 84 patients with OA were randomy divided into SH groups and transcutaneous electrical nerve stimulation group. The comprehensive function score of the knee joint were evaluated respectively before and after treatment. 68 patients were followed up at three months, six months and one year after treatment. Results The comprehensive function scone of the knee joint evaluated showed that there was no significantly different from two groups after five week＇ s treatment SH group was better than confrol group in the excellent and good rate in six month and one year after treatment. Conclusion The metaphasic effect of SH is effective and steady in treating initial middle knee osteoarthritis.

关 键 词：玻璃酸钠 疗效 骨关节炎 

分 类 号：R684.3[医药卫生—骨科学]